Final Inflation Reduction Act Guidance Risks Stifling Innovation for Rare Disease Community

QUINCY, Mass., June 30, 2023 /PRNewswire/ — Today, the Centers for Medicare and Medicaid Services (CMS) finalized a key component of the Inflation Reduction Act’s Medicare Drug Price Negotiation Program (MDPNP). Final Inflation Reduction Act Guidance Risks Stifling Innovation for Rare…